BioSpace News Archive

Operations Management Veteran Robert Sullivan Brings Over 30 Years of Experience to Bio-Pharmaceutical Startup

CVS Health and the CVS Health Foundation announced a total of nearly $1.25 million in grants to help underserved communities in Ohio increase access to food and health care.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing of an underwritten public offering of 5 million shares of its common stock for gross proceeds of $70 million,

Havn Life will collaborate on future clinical studies with Heroic Hearts Project to investigate effects of low-dosage psychoactive compounds on veterans the post-traumatic stress disorder (PTSD).

Neuropsychopharmacology recently published “Placebo Response Mitigation with a Participant-Focused Psychoeducational Procedure: A Randomized, Single-Blind, All Placebo Study in Major Depressive and Psychotic Disorders”.

Caris’ AI-powered predictor helps gauge which metastatic colorectal cancer patients will benefit from treatment with current standard of care regimen Exploratory analyses also found benefit in advanced esophageal/gastro-esophageal junction cancers and pancreatic ductal adenocarcinoma

Bluejay Diagnostics, Inc. (Bluejay, Acton, MA ) today announced a collaboration agreement with Toray Industries, Inc. (Toray, Tokyo, Japan ) to develop a minimally-invasive, point-of-care test for COV

LGC Maine Standards¹ announces the release of VALIDATE ® PTH to meet the linearity and calibration verification needs of clinical laboratories running the Roche cobas ® platform. The product (Order No. 303RO), which includes the analyte, Parathyroid Hormone, is formulated in a human serum matrix, using the CLSI EP06-A

Endobotics, LLC (“Endobotics” of the “Company”), a company with significant intellectual property assets and know how announced today that the United States District Court for the District of Delaware and the United State

Usona Institute has published a multigram-scale process describing the synthesis of 5-MeO-DMT in the open-access journal ACS Omega . The newly developed procedure emphasizes scalability, controllability, and reproducibility with detailed chemical and physical characterization to support further clinical research with 5-MeO-DMT as a potential treatment for mental health conditions such as depression, anxiety, addictio